The British-Swedish company AstraZeneca has declared the safety of its coronavirus vaccine. The corresponding statement was circulated by a pharmaceutical company, TASS reports.
The company explained that a detailed study of the health status of more than 17 million people vaccinated in the European Union (EU) and the UK with a coronavirus drug showed no data on an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia.
They also noted that as of March 8, 15 cases of deep vein thrombosis and 22 cases of pulmonary embolism were detected in the EU and the UK in those vaccinated. “This is much less than one would expect,” the company explained.
European countries have suspended or temporarily limited vaccination with AstraZeneca due to thrombosis in patients who have been vaccinated with it. Austria, Estonia, Latvia, Lithuania and Luxembourg have stopped using the drug from a specific batch of one million doses, which was supplied to 17 European countries. At the same time, Denmark, Iceland and Norway have stopped all their supplies of this vaccine.
According to the EMA, by March 12, 22 cases of thrombosis were recorded in the EU for three million people vaccinated with AstraZeneca. The regulator does not link this phenomenon with the use of the vaccine, but the investigation of deaths continues.